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MicroRNA 19a replacement 
partially rescues fin and cardiac 
defects in zebrafish model of Holt 
Oram syndrome
Elena Chiavacci1,†, Romina D’Aurizio2, Elena Guzzolino3, Francesco Russo2,4, 
Mario Baumgart5, Marco Groth5, Laura Mariani1, Mara D’Onofrio6, Ivan Arisi6, 
Marco Pellegrini2, Alessandro Cellerino7, Federico Cremisi7 & Letizia Pitto1
Holt-Oram Syndrome (HOS) is an autosomal dominant heart-hand syndrome caused by mutations in 
the TBX5 gene, a transcription factor capable of regulating hundreds of cardiac-specific genes through 
complex transcriptional networks. Here we show that, in zebrafish, modulation of a single miRNA is 
sufficient to rescue the morphogenetic defects generated by HOS. The analysis of miRNA-seq profiling 
revealed a decreased expression of miR-19a in Tbx5-depleted zebrafish embryos compared to the wild 
type. We revealed that the transcription of the miR-17-92 cluster, which harbors miR-19a, is induced 
by Tbx5 and that a defined dosage of miR-19a is essential for the correct development of the heart. 
Importantly, we highlighted that miR-19a replacement is able to rescue cardiac and pectoral fin defects 
and to increase the viability of HOS zebrafish embryos. We further observed that miR-19a replacement 
shifts the global gene expression profile of HOS-like zebrafish embryos towards the wild type condition, 
confirming the ability of miR-19a to rescue the Tbx5 phenotype. In conclusion our data demonstrate the 
importance of Tbx5/miR-19a regulatory circuit in heart development and provide a proof of principle 
that morphogenetic defects associated with HOS can be rescued by transient miRNA modulation.
Micro-RNAs (miRNAs) are evolutionarily-conserved noncoding RNAs approximately 22 nucleotides in length, 
which negatively regulate gene expression by translational repression or mRNA destabilization1,2. miRNAs have 
been implicated in numerous diseases3–5, including cancer6,7. The hypothesis that miRNA dysregulation is part 
of pathophysiological mechanisms underlying heart disease was first suggested by distinctive patterns of miRNA 
expression discovered in healthy and diseased mouse and human hearts (reviewed in8–10). miRNAs are now demon-
strated to be actively involved in all aspects of cardiac remodeling, growth, proliferation, apoptosis, conductance 
and contractility. Thanks to their small size, their conserved and well characterized sequences, and their ability to 
impact multiple mRNAs, which are often functionally related, miRNAs are able to modulate complex physiological 
phenotypes by fine-tuning entire functional networks and therefore are attractive potential targets for complex 
disease therapy11,12. Holt Oram syndrome (HOS) is an autosomal dominant disorder characterized by cardiac and 
upper limb abnormalities13. Mutations in T-box transcription factor 5 (TBX5) underlie this syndrome14,15. Even 
small perturbations in TBX5 expression have significant effects on the HOS phenotype and modify the expression 
of hundreds of genes as shown in a murine model of HOS16,17. Interestingly, although TBX5 has been exclusively 
characterized as transcriptional activator, about 30% of the genes identified by microarray as being differentially 
expressed in tbx5 haploinsufficient mice are upregulated. This result suggests that TBX5 exerts its action at least 
in part via indirect mechanisms, such as, for example, activation of repressors. Our working hypothesis is that 
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miRNAs are critical negative effectors of TBX5: more specifically the peculiar ability of each miRNA to modulate 
many targets might contribute to expand the range of influence of TBX5 which is a pivotal gene in heart morpho-
genesis. In line with our hypothesis, we identified in zebrafish HOS model those miRNAs embedded in genes highly 
sensitive to Tbx5 dosage. In our previous work we showed that misregulation of miR-218, has a severe impact on 
heart development by affecting early heart morphogenesis18.
In the present work we first performed massive parallel sequencing of the small RNAs in zebrafish embryos 
depleted for Tbx5 by morpholino injection (Tbx5-morphants). Then, by analysing the RNA profiles, we identified 
the miRNAs downregulated in Tbx5-morphants. Among several differentially regulated miRNAs we selected miR-
19a because of its capability to significantly rescue the cardiac and pectoral fin defects caused by Tbx5 depletion 
and because of its capability to improve the Tbx5 morphant viability when co-injected with the morpholino against 
Tbx5. By in situ hybridization, we demonstrated that the proper expression of crucial cardiac genes is restored by 
miR-19a replacement. Moreover we showed, by microarray analysis, that gene expression profile of Tbx5 morphants 
co-injected with miR-19a mimic clusters together with WT embryos. Furthermore several miR-19 targets, some of 
them with relevance for cardiovascular development, are found to be up regulated by Tbx5 depletion and restored 
to WT condition by miR-19a co-injection.
Results
Tbx5a/b downregulation misregulates miRNA expression during zebrafish development. In 
order to identify miRNAs modulated by Tbx5, we simultaneously depleted both zebrafish Tbx5 paralogs19,20 by 
microinjecting embryos at 1-cell stage with morpholinos against Tbx5a and Tbx5b (MO-Tbx5a and MO-Tbx5b). 
These morpholinos have been already extensively used to functionally analyze Tbx5 paralogs19–23. About 70% of 
embryos injected with 1.5ng of MO-Tbx5a and 1.5 ng of MO-Tbx5b showed cardiac and fin defects (Fig. 1A,B). 
Embryos showing the typical heartstring (hts) phenotype associated to Tbx5 downregulation18,23 were manually 
selected at 48hpf under microscope (Fig. 1C). Total RNA was extracted from Tbx5 depleted embryos and from 
embryos microinjected with the same amount of control morpholino (MO-Ct)18. miRNA profiles were performed 
by next generation sequencing (NGS). We identified 8 miRNAs with a fold change (FC) higher than 1.8 and a num-
ber of reads per million (rpm) higher than 200 of which 6 down- and 2 up-regulated in hts morphants compared 
to MO-Ct injected embryos (Fig. 1D). Next, we focused our attention on miRNAs showing down-regulation as a 
consequence of Tbx5 depletion, which is the premise for a Tbx5 direct regulation. To test whether Tbx5 can induce 
the expression of these miRNAs, we over-expressed Tbx5 in two different mouse cardiac cell lines, P19CL624,25 and 
HL1 cells26. We showed by qRT-PCR analysis that the expression levels of miR-219, miR-190b, miR-19a, miR-7a 
and miR-7b significantly increase as a consequence of Tbx5 overexpression (Fig. 1E).
miR-19a is able to partially rescue heart/fin defects induced by MO-Tbx5. We investigated whether 
miR-219, miR-190b, miR-19a, 130a and miR-7b could be effectors of Tbx5 activity by testing whether the replace-
ment of any of these miRNAs alone was able to rescue morphological defects induced by Tbx5 depletion18,23. The 
tool used for this screening is the transgenic Tg(Myl7:EGFP) zebrafish line showing EGFP-labelled cardiomyo-
cytes. Since we had already shown that the penetrance of the MO-Tbx5b phenotype was lower compared to that 
of MO-Tbx5a18, we used only MO-Tbx5a for all the subsequent Tbx5 depletion experiments. Tg(Myl7:EGFP) 
embryos were injected with 1.5 ng of MO-Tbx5a and 0.25 ng of each miRNA mimic. Co-injection of miR-130a 
and miR-219 was ineffective while co-injection of miR-7b and miR-190b even worsened the Tbx5a morphant 
phenotypes (Fig. S1). On the other hand, doses below 1 ng of miR-19a mimic significantly reduce both cardiac and 
fin defects (Fig. 2A–C). Co-injection of MO-Tbx5a and non-coding miRNA mimic (miR-Ct) does not improve 
morphant phenotype (Fig. 2A–C).
We questioned whether the injection of miR-19a would improve the viability of Tbx5a morphants. Figure 2D 
shows that about 60% of the Tbx5a morphants co-injected with 0.25/0.5 ng of miR-Ct die around the 5th–6th day of 
development, when the oxygen exchange by passive diffusion is no longer sufficient to sustain aerobic metabolism 
and a functioning circulatory system becomes necessary for survival. Less than 20% of Tbx5a morphants were 
still viable at the 11th day of development. Conversely, more than 60% of morphants co-injected with 0.25 ng of 
miR-19a mimic were still alive at the 12th day of development (Fig. 2D). In line with the dose-dependency of the 
cardiac rescue data (Fig. 2A,B), co-injection of 0.5 ng of miR-19a was less effective than a lower dose in improving 
viability. To explain this result we speculate that a specific dosage of miR-19a would be necessary for proper heart 
development. Moreover, since miRNAs are fine tuned rheostatic regulators of biological processes by targeting 
many mRNAs, an excessive amount of a single miRNAs can lead to nonspecific repression of unrelated mRNAs, 
causing a worsening of the phenotype.
Replacement of miR-19a decreased the severity of cardiac defects produced by Tbx5b depletion too, although it 
did not increase the number of normal embryos (Fig. 2E). This result is in accordance with the partial redundancy 
of zebrafish Tbx5 paralog functions20.
Tbx5 modulation affects miR-17-92 cluster expression. We investigated whether Tbx5 directly reg-
ulates the expression of the miR-17-92 cluster, to which miR-19a belongs. The functional analysis of miR-17-92 
members is complicated in vertebrates by the existence of several paralogs (Fig. 3A,B). However, there is only one 
miRNA-19a in fish as well as in human and rodent genomes27.
We scanned the genomic sequence upstream the microRNA cluster for Tbx5 consensus binding sites by 
TRANSFAC program28. A potential Tbx5 binding site was identified about 4500 bp upstream the putative tran-
scription starting site of the miR-17-92 cluster. A sequence of 1600 bp spanning the Tbx5 binding site was cloned 
into the pGL3 promoter vector upstream of the luciferase reporter gene generating the pGL3-MIR construct. 
Transactivation assays were performed in HL1 cells transfected with different amounts of the Tbx5 expression 
vector and with pGL3-MIR in the presence of the pRL-TK vector as internal standard. Co-transfection of increasing 
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doses of the pcDNA-Tbx5 resulted in a progressive increase of luciferase activity (Fig. 3C). Next, the transactivating 
ability of Tbx5 on the pGL3-MIR vector was compared with the capability of Tbx5 to transactivate the pGL3-Anf 
construct, which expresses luciferase under the control of the atrial natriuretic factor (Anf) promoter, an established 
direct target of Tbx516. A dose of 500 ng of the Tbx5 plasmid increases the activity of the pGL3-MIR and pGL3-Anf 
vectors by 2.5- and 5-folds respectively (Fig. 3D). In line with this data, transfection of a siRNA able to almost 
halve endogenous Tbx5 expression decreased the luciferase activity both in pGL3-MIR and pGL3-Anf (Fig. 3E).
Downregulation of the miR-17-92 cluster expression in Tbx5a morphants was further supported by whole 
mount In Situ Hybridization (ISH) experiments using a riboprobe for the primary transcript of the miR-17-92 
cluster. We observed that more than 30% of the MO-Tbx5a injected embryos have reduced miR-17-92 expression 
in the cardiac district (Fig. 3F,G). Since the first consequence of Tbx5a depletion was the lack of pectoral fins, we 
could not evaluate miR-17-92 cluster modulation in this district. Embryos with reduced miR-17-92 hybridization 
signal always showed a strong phenotype and absence of pectoral fins. More specifically, pectoral fins, whose 
presence is suggestive of WT-like phenotype (20% of Tbx5a-morphants, Figs S1 and S2), never showed visible 
reduction of the ISH signal. Overall the data are consistent with miR-17-92 cluster modulation by Tbx5a also in 
the cardiac tissue of intact embryos.
These data led us to investigate if the replacement of other cluster members might rescue defects generated by 
Tbx5a depletion. To address this issue we assayed one member for each of the miRNA families which are present 
within the miR-17-92 cluster: miR-18a as member of miR-17 family, miR-19b for miR-19 family and miR-92a 
which belongs to miR-25 family. Data presented in Figure S2 demonstrate that none of the tested miRNA was able 
to reduce Tbx5a morphant defects.
Figure 1. Tbx5a/b downregulation dysregulates miRNA expression during zebrafish development.  
(A,B) Cardiac (A) and fin (B) analysis of 72 hpf embryos injected with 3 ng of MO-Ct or 1.5 ng of MO-Tbx5a 
and 1.5 ng of MO-Tbx5b. (C) Images representative of WT-like and heartstring Tg(Myl7:EGFP) morphants 
at 72 hpf. Red and black arrows point to heart and fins, respectively. Stars mark fin absence. Scale bar 100 μ m. 
Heart higher magnification in insets. (D) List of miRNAs that showed a positive or negative fold change ≥ 1.8 
and a number of reads per million (rpm) higher than 200 in the Tbx5 depleted embryos (MO-Tbx5a + MO-
Tbx5b). (E) QRT-PCR analysis of mouse P19CL6 proliferating cells or HL1 cells 48 hrs after transfection with 
Tbx5 expressing vector or with an empty vector. t-test was used for statistical analysis.
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Figure 2. miR-19a mimic is able to partially rescue heart/fin defects induced by MO-Tbx5. (A–C) Analysis 
of 72hpf Tbx5a morphants. miR-19a or miR-Ct mimics, at the reported doses, were co-injected with 1.5 ng of 
MO-Tbx5a in Tg(Myl7:EGFP) embryos. The percentage of embryos with the indicated heart (A) or pectoral 
fin (B) defects was averaged across multiple independent experiments carried out in double blind. The total 
number of analyzed Tbx5 morphant embryos were as follows: not co-injected n = 100; miR-Ct co-injected 
n = 272 (0.5 ng), n = 214 (0.25 ng), n = 164 (0.125ng); miR-19a co-injected n = 200 (0.5ng), n = 132 (0.25 ng), 
n = 260 (0.125 ng). For each miR-19a mimic dose, the equivalent dose of miR-Ct was always injected as control. 
For all tested doses, differences between miR-Ct and miR-19a were significant (Fisher’s test P < 0,0001). In (C) 
images representative of the different phenotypes. Red scale bar = 10 μ m, hts, heartstring; v, ventricle; a, atrium. 
White arrows indicate cardiac chambers, black arrow and star indicate fin presence and absence respectively. 
(D) Embryos injected with the indicated mix of morpholino and miRNA mimics were followed for 11 days, 
daily recording the number of surviving embryos. Curves were compared by long-rank test analysis. The total 
number of analyzed embryos were as follows: miR-Ct co-injected n = 60 (0.5 ng), n = 116 (0,25 ng); miR-19a 
co-injected n = 71 (0,5 ng), n = 97 (0,25 ng). (E,F) Analysis of 72hpf Tbx5b morphants co-injected with 4 ng of 
Tbx5b morpholino and 0.25 ng of miR-19a or miR-Ct mimics. hts: heartstring phenotype; mild defects: general 
cardiac defects; WT: wild type heart. NO fins: pectoral fins absence, WT fins: wild type pectoral fins.
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Figure 3. Tbx5 modulation affects miR-17-92 cluster expression. (A,B) Schematic representation of miR-
17-92 paralogs in zebrafish and mouse. The color code identifies miRNAs of the same family. (C) Relative 
Luciferase/Renilla activity in HL1 cells transfected with pGL3-MIR (containing a fragment of 1600 bp of miR-
17-92 cluster promoter upstream of the luciferase reporter gene) and the pRL-TK renilla vector in the presence 
of increasing doses (0–500 ng) of pCMV-Tbx5 vector; (D,E) Relative Luciferase/Renilla activity in HL1 cells 
transfected with 500 ng of pGL3-MIR or 500 ng of pGL3 vector containing the Anf promoter (Anf) in the 
presence of (D) 500 ng of CMV-Tbx5 or the empty CMV vector; (E) Tbx5 specific siRNA (siRNA-Tbx5) or 
nonspecific siRNA (siRNA Ct). The y-axis represents fold activation of reporter normalized by a dual-luciferase 
system. t-test was used for statistical analysis *P < 0.05. (F) miR-17-92 cluster ISH on 72 hpf embryos injected 
with 1.5 ng of MO-Ct or 1.5 ng of MO-Tbx5a. Examples of the different phenotypes observed in the Tbx5 
morphants are shown. Red and green arrows indicate heart and fins, respectively. Dashed arrows highlight the 
absence of expression, thicker arrow indicates over-expression. Scale bar 100 μ m. (G) Quantification of the 
different phenotypes as in (F). A color code is used to identify the different phenotypes: only the WT (purple) 
phenotype is present in embryos injected with MO-Ct (upper panel of 3F), while 3 different phenotypes are 
recognizable in embryos injected with MO-Tbx5a. Fisher’s test P value is reported. n, numbers of embryos 
analyzed.
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miR-19a dysregulation affects zebrafish heart development. In order to investigate the effect 
of miR-19a dysregulation during early zebrafish development, we performed both gain- and loss-of-function exper-
iments (GOF and LOF). Effects on heart morphogenesis and fin development were assessed by confocal analysis 
and bright-field microscopy, respectively. Increasing doses of miR-19a injected in Tg(Myl7:EGFP) embryos raised 
the frequency and severity of cardiac defects generated by Tbx5 depletion (Fig. 4A,B). In the less severe phenotype, 
only looping was affected (phenotype 1, Fig. 4A,B). Increasing the miRNA dose caused shrinkage of the ventricle, 
atrium bilobation and size reduction (phenotype 2, Fig. 4A,B). In the most severe phenotype, two small deformed 
hearts were detectable (phenotype 3, Fig. 4A,B). These hearts were still capable of contraction although with a very 
irregular rhythm. Strikingly, while injection of 2 ng of miR-Ct induced 20% of unlooped hearts, more than 50% of 
the miR-19a injected embryos presented cardiac defects of variable severity (Fig. 4B). The lowest dose of 0.13 ng, 
which was able to rescue the Tbx5a morphant phenotype (see Fig. 2A,B) did not cause any apparent cardiac defects 
(Fig. 4B). Fin lack or defects were never detected in miR-19a overexpressing embryos.
To evaluate the impact of miR-19a dysregulation on vascular integrity we also injected miR-19a mimic in 
Tg(flk1:EGFP;myl7:dsRED) transgenic line. Doses up to 1 ng of miR-19a mimic did not cause visible alterations 
in vascular structures (Fig. S3).
We performed LOF experiments using a specific morpholino to block the activity of miR-19a (MO-19a),with 
a non-coding morpholino as control (MO-Ct). Even a high dose (10 ng) of MO-19a did not affect embryo mor-
phology (Fig. S4A,B) but it was able to rescue the morphological defects caused by miR-19a over-expression 
(Fig. S4C). We speculate that if miR-19a and Tbx5 are part of the same pathway, their LOF effects should be 
Figure 4. miR-19a dysregulation affects zebrafish heart development. (A,B) Tg(Myl7:EGFP) embryos 
were injected with increasing amounts of miR-Ct or miR-19a mimics. (A) Images of representative 72 hpf 
Tg(Myl7:EGFP) embryo phenotypes. (B) Percentage of embryos with the indicated phenotypes, averaged across 
multiple independent experiments carried out in double blind. (D,E) Phenotypes of 72 hpf Tg(Myl7:EGFP) 
embryos co-injected with 0.5 ng of MO-Tbx5a and with 8ng of MO-19a or MO-Ct. N, total numbers of 
analyzed embryos. Scale bar 100 μ m. hts: heartstring phenotype; mild defects: general cardiac defects; WT: wild 
type heart. NO fins: pectoral fins absence, WT fins: wild type pectoral fins. P values by Fisher’s test.
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synergic. We injected Tg(Myl7:EGFP) embryos with 0.5 ng of MO-Tbx5a. This is a sub-phenotypic dose which 
generates less than 20% of mild cardiac defects and 10% of embryos without pectoral fins (compare Fig. 4C,D 
with Fig. 2A,C). Co-injection of the sub-phenotypic dose of MO-Tbx5a with 8 ng of MO-19a strongly increased 
the number of heart and pectoral fin defects suggesting a synergistic interaction between miR-19a and Tbx5a. 
Although miR-19a down-regulation alone was not sufficient to trigger the HOS phenotype in zebrafish, these data 
indicate that dysregulation of miR-19a level impacts heart development.
Genome-wide analysis of miR-19-induced rescue of Tbx5 morphants. To characterize the impact 
of miR-19a on molecular HOS phenotype, we focused on cardiac markers known to be deregulated in Tbx5a mor-
phants/hts mutants. The Tbx5 target natriuretic peptide precursor A (Anf)29 and the sinus venosus (SV)- atrioven-
tricular junction (AVJ) differentiation marker bmp430 have been previously shown to decrease their expression after 
Tbx5a depletion20,23. On the other hand, notch1b and versican a (Vcana) showed expanded expression compared to 
the WT in which the expression is restricted to the AVJ18,20,30. Vcana and bmp4 were also exploited as pectoral fin 
development markers because of their expression in the apical district and within the fin buds in case of bmp430,31. 
A high percentage of Tbx5a morphants co-injected with miR-19a mimic showed at 48hpf a recovered expression 
of the tested genes in both, cardiac and fin districts (Fig. 5). In addition, the recovery of the WT expression of the 
proepicardial markers Tbx18 and Wt1a indicates that the replacement of miR-19a is able to rescue the absence 
of proepicardial specification which is a feature of hts mutants32 (Fig. 5). We also analyzed the effect of miR-19a 
co-injection on valve morphology using the hemizygous Tg(tie-2:GFP) line, which allows to visualize the valve 
tissue. While alteration of Tbx5 expression causes an expansion of Tie2 expression in zebrafish embryos18, miR-19a 
replacement was able to restore the Tie2 expression in a high percentage of Tbx5a morphants (Fig. S5).
Furthermore, we explored the impact of miR-19a replacement at the global gene expression level, by comparing 
the microarray profiles of 24hpf zebrafish embryos co-injected with MO-Ct and miR-Ct (WT phenotype) to the 
profiles of MO-Tbx5a morphants co-injected with miR-Ct (hts phenotype), or with miR-19a (rescued phenotype). 
We first investigated the overall relationship between sample expression profiles using unsupervised hierarchical 
clustering analysis based on probe intensity signals. The dendrogram in Fig. 6A shows that, at probe-level, the 
genome-wide expression profile of rescued embryos is more similar to embryos with WT phenotype rather than 
to embryos presenting the hts phenotype. The reliability of the obtained cluster was confirmed by bootstrap 
analysis33 (see Fig. 6 legend and Supplementary Methods for details). In addition we employed principal compo-
nent analysis (PCA) of probes log-transformed expression values to elucidate the main sources of variation. In 
the space of the first two principal components (PCs), which account for 61% (PC1) and 19% (PC2) of the total 
variance, the biological replicates of the three conditions were well-separated (Fig. 6B). PC1 discriminates hts 
from WT while rescued embryos are close to the WT on this axis (Fig. 6B). PC2 instead discriminates WT from 
morpholino-injected embryos independently from the miR-19a status.
Next, we measured the impact of Tbx5a depletion on the global gene expression patterns of embryos treated 
and untreated with miR-19a. We first identified genes that were differentially expressed (expression FC > 1.3, 
p < 0.05, FDR < 0.05) in MO-Tbx5a morphants compared to the MO-Ct. Then we intersected the identified 
genes with the set of differentially-expressed genes in embryos with rescued profiles compared to MO-Tbx5a 
morphants. We found 4963 genes, corresponding to 59,6% of the gene set altered in MO-Tbx5a embryos, that had 
significant changes in their expression in rescued embryos. Those genes and their log2 FC are shown in Fig. 6C. 
Interestingly, most of them (98,7%) resulted inversely modulated (see IIQ and IVQ in Fig. 6C) and their relative 
expression levels were highly anticorrelated (Pearson R2 = − 0.9, p < 2.2e−16). Since those genes are both direct and 
indirect targets of miR-19a, in order to identify putative direct targets, we focused on transcripts down-regulated 
in miR-19a-coinjected Tbx5 morphants vs Tbx5 morphants (IIQ). Among the targets predicted by two algo-
rithms (TargetScanFish and Pita) we found 293 transcripts (shown in red in Fig. 6C, Table S1) which were not 
only down-regulated in MO-Tbx5 + miR-19a embryos compared to MO-Tbx5 morphants, but also up-regulated 
in Tbx5 morphants vs control embryos. These transcripts represented an enriched subset (hypergeometric test 
p = 0.0001) compared to the background of predicted miR-19a targets for all expressed transcripts measured using 
the array. On the other hand, the number of predicted putative miR-19a targets in the IVQ (transcripts downreg-
ulated in MO-Tbx5 morphants and upregulated by the presence of miR-19a) is below the expected background 
frequency (hypergeometric test p < 2.2e−16). Furthermore, to evaluate the influence of modulated miR-19a targets 
on discriminating between hts and WT phenotypes, we selected from PCA the probes with the relative highest 
absolute loadings (10th percentile) along the PC1. We then selected 7834 probes, accounting for 49.1% of the total 
weight. These probes corresponded to 5552 unique genes and all the 293 predicted mir-19a targets were included 
in this list. The most significantly represented biological processes (p < 0.001) in this gene set, based on Gene 
Ontology (GO) classification34 were developmental process, multicellular organism and anatomical structure 
development (Fig. S6).
Q-RT-PCR analysis performed on 7 selected genes validated the array results (Fig. S7A). Among them the 
cardiac regulators MEF2Ca and Camk2n1a were tested by means of Dual Luciferase assays carried out on cloned 
3’UTR. The ability of miR-19a to reduce the luciferase activity in a dose-dependent manner support its direct 
control on these crucial cardiac genes (Fig. S7B).
Discussion
In summary, our data indicate that miR-19a acts as a Tbx5 negative effector regulating several aspects of cardio-
vascular development.
Despite substantial progress in the comprehension of main roles played by transcription factors in cardiac 
development, there are gaps in our understanding of the interconnections between cardiogenic transcription 
factors and their downstream effector genes. Tbx5 is a crucial player in heart development. A network of cardiac 
transcription factors has been suggested as responsible of the complex Tbx5-dependent regulation17. In this work, 
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using zebrafish as HOS model system, we show that miR-19a has a crucial role in the Tbx5 regulatory network. 
We found that miR-19a is down-regulated in Tbx5 depleted zebrafish embryos and that Tbx5a modulation affects 
the expression of the miR-17-92 cluster, which hosts miR-19a. Importantly, we showed that modulating miR-19a 
levels partially rescues cardiac and pectoral fin defects due to Tbx5 downregulation and increases the viability of 
Tbx5 morphants.
The miR-17-92 cluster has been largely studied as oncogene in tumor and, more recently, its role in cardio-
vascular system has been also highlighted35,36. This cluster plays a role in angiogenesis37 and it is able to induce 
cardiomyocyte proliferation in post-natal and adult hearts38. While Ventura in 2008 showed that deletion of 
miR-17-92 in mice causes ventricular septal defects, Danielson et al., in 2013 observed that overexpression of this 
Figure 5. miR-19a replacement partially rescues cardiac marker expression in Tbx5 morphants. WT 
embryos were co-injected with 1.5 ng of MO-Tbx5a and 0.25 ng of miR-Ct (MO-Tbx5a) or 0.25 ng of miR-
19a mimics (MO-Tbx5a + miR-19a). WT embryos co-injected with 1.5 ng of MO-Ct and 0.25 ng of miR-CT 
were used as control. At 48 hpf, 15–20 embryos from each thesis were fixed for ISH analysis. A small number 
of embryos were also grown up to 72 hpf and screened by optical microscopy to verify that the percentages 
of embryos with cardiac defects and fin absence were the expected. Whole mount ISH. Ventral view of 48hpf 
embryos is shown. For versicana and bmp4 probes, dorsal view is also shown (right side) to highlight the fin 
bud (only bmp4) and fin apical fold signals. Black scale bars:100 μ m. At bottom of the figure, quantifications 
of different hybridization signals were reported. 1 = MO-Ct + miR-Ct; 2 = MO-Tbx5 + miR-Ct and 3 = MO-
Tbx5 + miR-19a.
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cluster in cardiac and smooth muscle tissues induces dilated, hypertrophic cardiomyopathy, and arrhythmia27,39. 
These data highlight the importance of this cluster in regulating cardiac development. Moreover, very recently, 
Han et al.40 reported also forelimb defects in miR-17 ~ 92 deleted mice. More specifically, limb and digit malfor-
mations are some of the consequences of monoallelic microdeletions involving the miR-17 ~ 92 cluster in a subset 
of individuals with Feingold syndrome40,41.
Our data show that, although Tbx5 is able to modulate the miR-17-92 cluster, only miR-19a is effective in rescu-
ing cardiac and fin defects of Tbx5a morphants. Also mir-19a is the only member of the miR-17-92 cluster which 
resulted significantly decreased in the NGS analysis by Tbx5 depletion. This difference among miRNAs of the same 
cluster might be due to the extensive post-transcriptional regulation which characterizes miRNA maturation42,43.
In accordance with a cardiac role of the miR-17-92 cluster, we showed that dysregulation of miR-19a levels 
alters heart development. Overexpression of miR-19a induces defects of dose-dependent severity ranging from 
looping defects to cardia bifida (F 4A,B). Recently, overexpression of miR-19b has been shown to impact left-right 
symmetry and cardiac development of zebrafish embryos; inhibition of the Wnt signaling pathway by miR-19b 
direct ctnnb1 targeting has been indicated as its possible mechanism44. However, in our data the expression of 
ctnnb1 results unchanged in Tbx5a morphants and it is not decreased by co-injection of miR-19a modulation.
Downregulation of miR-19a by morpholino microinjection was ineffective even using very high doses (10 ng) of 
MO-19a. In line with this results, Han et al., characterizing an allelic series of genetically engineered mice harboring 
selective targeted deletions of individual components of the miR-17 ~ 92 cluster, showed that the cardiac defects 
observed in the miR-17~92–null mice27 were only detected upon deletion of the entire cluster40. A minimal effect 
of miRNA-mediated loss of function is frequently observed in experimental approaches45–47. An explanation for 
this phenomenon might be the existence of compensatory mechanisms which re-balance a regulatory network 
when the expression of a single component is slightly altered47. However, a general observation is that the miRNA 
effect can become evident in conditions of stress or injury which causes a strong unbalance48,49. Our experiments 
performed with sub-phenotypic doses of MO-Tbx5a (Fig. 4C,D) are in line with these data and support the 
hypothesis of synergism between miR-19a and Tbx5a in zebrafish.
At genome-wide level, we showed that miR-19a injection is able to rescue the global gene expression pro-
file of Tbx5 morphants while microarray data clearly demonstrate that more than a half of the genes altered by 
Tbx5a depletion are affected by miR19a. Furthermore, the majority of transcripts significantly upregulated in 
MO-Tbx5a vs. WT embryos are significantly downregulated in MO-Tbx5a + miR-19a vs. Mo-Tbx5a (Fig. 6C, 
IIQ) and viceversa (Fig. 6C, IVQ). The remarkable impact that miR-19a has even at the global gene expression 
level was supported by the observation that putative miR-19a targets are enriched in transcripts upregulated in 
MO-Tbx5 vs. WT embryos and downregulated by miR-19a co-injection (Fig. 6C, IIQ) compared to the other 
classes of modulated transcripts.
Among these putative targets MEF2CA, a transcription factor which physically interacts with Tbx5 to syn-
ergistically activate gene transcription50, has nine putative miR-19 binding sites, making it the best candidate 
among miR-19a targets. Increasing MEF2C levels in the presence of a Tbx5 decrease might generate a strong 
unbalance between these two interacting TFs. It has been demonstrated that the relative levels of crucial cardiac 
TFs working within complexes can be more important for heart development than the absolute levels of these 
regulators: disruption of these dosage-sensitive interactions could be one of the mechanistic cause of CHDs51. 
Besides MEF2CA, also MEF2AA, which is expressed in zebrafish embryonal cardiomyocytes and it is required for 
cardiac contractility52, is anti-regulated by miR-19. Camk2n1a, an inhibitor of the calcium/calmodulin-dependent 
protein kinase II(CaMKII), might be also a strong candidate target. CaMKII is necessary for proper heart and fin 
development and its expression has been shown to be dependent on Tbx5 activity53. More specifically, Tbx5 might 
Figure 6. Genome-wide analysis of miR-19-induced rescue of Tbx5 morphants. At 24 hpf about 50 embryos 
from MO-Tbx5a embryos, MO-Tbx5a + miR-19a embryos and control embryos (generated as described in 
legend of Fig. 5) were collected and total RNA was extracted for microarray analysis. (A,B) The dendrogram 
from the hierarchical clustering analysis (A) and first two PCs from PCA analysis (B) are shown. Scores on 
each dendrogram node in A report the approximately unbiased (AU) probability values as implemented in 
CONSEL56 and represent the statistical significance on a 1 to 100 scale estimated by bootstrap analysis. (C) Log2 
(FC) of differentially expressed transcripts are shown: MO-Tbx5a/miR-Ct (x axis) and MO-Tbx5a + miR-19a/
MO-Tbx5a (y axis). Thick marks along the sides are rug plots which explain the density of the represented data. 
Selected putative miR-19 targets are shown in red. R2 is the square of the Pearson correlation coefficient.
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affect CaMKII expression by acting on its inhibitor through miR-19a modulation. Indeed, dual luciferase assays 
performed with reporter plasmids carrying the cloned sequences of the MEF2CA-and Camk2n1a-3’UTR support 
the miR-19a direct control (Fig. S7B). We also identified several potassium and sodium channel forming proteins 
such as SCN8aa, cacna1ab and kctd8, kctd12.2, kctd15b, this observation is in line with the important role played 
by Tbx5 in cardiac contractility54,55. Moreover, the selection of putative miR-19a targets includes also a number of 
chromatin remodeling proteins (Smarca2, Smarcc1a, Hmga1b, DNMT4, Kdm5ba and Wdr5).
As a whole,these results indicate the complexity of miR-19a functions and its crucial role in the Tbx5 regulatory 
circuit. Besides providing a tool for identifying new possible targets for HOS, our study in principle shows that 
modulating miR-19a can positively impact cardiac defects associated with a reduced dosage of Tbx5.
Materials and Methods
More details can be found in SI Materials and Methods
ZebrafishLines. Wild-type AB, Tg(flk1:EGFP), Tg(Myl7:EGFP) and Tg(Tie2:GFP) lines were used in these 
studies. Zebrafish were raised and maintained under standard laboratory conditions (Westerfileld M zebrafish 
book) in Zebrafish Housing Systems (Tecniplast, Varese, Italy).
The zebrafish facility, where all the experiments have been performed, is part of the CENTRO di BIOMEDICINA 
SPERIMENTALE (CBS) of the Area della Ricerca del CNR, Via Moruzzi 1, 56124 Pisa. The zebrafish facility has 
been authorized by the Italian Ministry of Health with the authorization n°297/2012-A of the 12/21/2012.
The corresponding author declares that all the methods were carried out in accordance with the approved 
guidelines and that all experimental protocols were approved by the Italian Ministry of Health. Moreover all the 
technitians and researcher who take care of the animals and perform the experiments are appropriately trained 
by attending specific courses.
Microinjection. One-cell stage embryos were injected with a constant injection volume (1 nl, confirmed by 
volume analysis) using a microinjector (Tritech Research, Los Angeles CA USA). The miRNA mimics used are 
listed in Table S2.
Morpholinos. MO-Tbx5a and MO-Tbx5b (Gene Tools) were already described in18. The morpholino tar-
geting miR-19a and MO-Ct are the following: MO-miR-19a, CATCAGTTTTG CATAGATTTGCACA; MO-Ct, 
CCTCTTACCTCAGTTACAATTTATA.
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